Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 172

1.

Comments on "light-emitting diode therapy (ledt) before matches prevents increase in creatine kinase with a light dose response in volleyball players".

Nampo FK, Weiss C, Porzsolt F.

Lasers Med Sci. 2016 Apr 28. [Epub ahead of print] No abstract available.

PMID:
27126413
2.

[Prevention must become more efficient].

Porzsolt F, Kamga Wambo GO, Rösch MC, Weiß C.

Dtsch Med Wochenschr. 2016 Apr;141(9):651-3. doi: 10.1055/s-0042-101669. Epub 2016 Apr 28. German.

PMID:
27123732
3.
4.

WITHDRAWN: Immunotherapy for advanced renal cell cancer.

Coppin C, Porzsolt F, Autenrieth M, Kumpf J, Coldman A, Wilt TJ.

Cochrane Database Syst Rev. 2015 Dec 29;(12):CD001425. doi: 10.1002/14651858.CD001425.pub3. Review. No abstract available.

PMID:
26713838
5.

Clinical Economics and Nursing.

Porzsolt F.

Rev Lat Am Enfermagem. 2015 Nov-Dec;23(6):989-90. doi: 10.1590/0104-1169.0000.2640. English, Portuguese, Spanish. No abstract available.

6.

[Comments on the PREFERE study].

Porzsolt F.

Urologe A. 2015 Oct;54(10):1435-6. doi: 10.1007/s00120-015-3937-6. German. No abstract available.

PMID:
26271290
7.

Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences.

Bauer K, Schroeder M, Porzsolt F, Henne-Bruns D.

J Gastric Cancer. 2015 Mar;15(1):10-8. doi: 10.5230/jgc.2015.15.1.10. Epub 2015 Mar 31. Review.

8.

Benefits and risks of breast cancer screening.

Wöckel A, Janni W, Porzsolt F, Schmutzler R.

Oncol Res Treat. 2014;37 Suppl 3:21-8. doi: 10.1159/000363595. Epub 2014 Aug 29. No abstract available.

PMID:
25195829
9.

Can perioperative chemotherapy for advanced gastric cancer be recommended on the basis of current research? A critical analysis.

Bauer K, Porzsolt F, Henne-Bruns D.

J Gastric Cancer. 2014 Mar;14(1):39-46. doi: 10.5230/jgc.2014.14.1.39. Epub 2014 Mar 31.

10.

Validity of the MAGIC study: sufficient for recommendations?

Bauer K, Porzsolt F, Henne-Bruns D.

Hepatogastroenterology. 2013 Oct;60(127):1822-4.

PMID:
24624448
11.

The risks of information in health care: do we need a new decision aid?

Porzsolt F, Thomaz TG, Constâncio TI, Silva-Júnior AG, Nóbrega AC.

Clinics (Sao Paulo). 2013 Sep;68(9):1177-9. doi: 10.6061/clinics/2013(09)01. No abstract available.

12.

[PREFERE--the German prostatic cancer study].

Porzsolt F.

Urologe A. 2014 Mar;53(3):388-9. doi: 10.1007/s00120-013-3286-2. German. No abstract available.

PMID:
23975217
13.
14.

Balancing conflicts of interest.

Porzsolt F.

Dtsch Arztebl Int. 2013 Apr;110(16):286. doi: 10.3238/arztebl.2013.0286a. No abstract available.

15.

[What is the benefit of mammography? -- mammography screening: careful consideration required].

Porzsolt F.

Dtsch Med Wochenschr. 2013 Mar;138(9):410. doi: 10.1055/s-0032-1329036. Epub 2013 Feb 19. German. No abstract available.

PMID:
23423934
16.

[Validity of Recommendations for Secondary Prevention of Colon Cancer].

Porzsolt F, Ittner D, Henne-Bruns D.

Zentralbl Chir. 2015 Aug;140(4):390-6. doi: 10.1055/s-0032-1328074. Epub 2013 Jan 25. Review. German.

PMID:
23354740
17.

Visual AIDS for multimodal treatment options to support decision making of patients with colorectal cancer.

Hofmann S, Vetter J, Wachter C, Henne-Bruns D, Porzsolt F, Kornmann M.

BMC Med Inform Decis Mak. 2012 Oct 23;12:118. doi: 10.1186/1472-6947-12-118.

18.
19.

[Clinical economics: a concept to optimize healthcare services].

Porzsolt F, Bauer K, Henne-Bruns D.

Chirurg. 2012 Mar;83(3):268-73. doi: 10.1007/s00104-011-2200-y. German.

PMID:
22406680
20.

Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials.

Coppin C, Kollmannsberger C, Le L, Porzsolt F, Wilt TJ.

BJU Int. 2011 Nov;108(10):1556-63. doi: 10.1111/j.1464-410X.2011.10629.x. Epub 2011 Sep 27. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk